Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
FBRX
#3002
Forte Biosciences, Inc. Common Stock
32.420
0
USD
+5.95%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+5.95%
Aylık Değişim
+20.12%
6 aylık değişim
+10.46%
Yıllık Değişim
+10.46%
Önceki Kapanış
30.600
0
Open
32.420
0
Bid
Ask
Low
32.420
0
High
32.420
0
Hacim
17
Piyasalar
ABD Borsası
Sağlık Hizmetleri
FBRX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
540.35 K
590.45 K
840.28 K
1.46 M
6.58 M
13.89 M
—
Valuation ratios
Enterprise value
433.09 M
-10.45 M
-18.83 M
-6.92 M
127.23 M
301.71 M
—
Price to earnings ratio
—
—
-1.32
-0.83
-1.87
-5.79
-117.26
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
-2.25
—
—
—
—
Price to book ratio
—
—
0.47
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
0.22
-3.59
-4.43
—
Profitability ratios
Return on assets %
-0.76
-0.5
-0.33
-0.81
-0.58
-0.84
-0.92
Return on equity %
-0.79
-0.52
-0.36
-0.89
-0.68
-1.14
-1.14
Return on invested capital %
-3 279.79
-8 081.24
-8 739.62
-22.82 K
-33.73 K
-23.86 K
—
Gross margin %
—
—
—
100
100
100
—
Operating margin %
—
—
—
-2 890.21
-2 785.54
-2 602.47
—
EBITDA margin %
—
—
—
-2 789.41
-2 694.6
-2 508.84
—
Net margin %
—
—
—
-2 800.36
-2 700
-2 555.25
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
26.52
24.19
13.06
10.45
6.76
3.88
28.18
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.03
0.03
0.04
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-11.77
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
59.11
—
—
—
—
Net current asset value per share
—
—
59.7
—
—
—
—
Tangible book value per share
—
—
55.83
—
—
—
—
Working capital per share
—
—
55.13
—
—
—
—
Book value per share
—
—
55.83
—
—
—
—
Haberler
Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)
Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts
Forte Biosciences, 150 milyon dolarlık hisse arzını fiyatladı
Forte Biosciences halka hisse arz ediyor
Guggenheim, veri öncesi Forte Biosciences hisse notunu korudu
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know
Micron, Insmed among market cap stock movers on Thursday
Evercore ISI, Forte Biosciences hissesi için Outperform tavsiyesi ile takibe başladı
Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating
Guggenheim initiates Forte Biosciences stock with Buy rating on autoimmune therapy potential
Forte Biosciences Announces Pricing of $75 Million Public Offering
Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data - TipRanks.com